Suppr超能文献

利福平对人肝羟类固醇硫酸转移酶(SULT2A1)基因转录的正负调控:肝细胞核因子4α和孕烷X受体的作用

Positive and negative regulation of human hepatic hydroxysteroid sulfotransferase (SULT2A1) gene transcription by rifampicin: roles of hepatocyte nuclear factor 4alpha and pregnane X receptor.

作者信息

Fang Hai-Lin, Strom Stephen C, Ellis Ewa, Duanmu Zhengbo, Fu Jiaqi, Duniec-Dmuchowski Zofia, Falany Charles N, Falany Josie L, Kocarek Thomas A, Runge-Morris Melissa

机构信息

Institute of Environmental Health Sciences, Wayne State University, Detroit, Michigan 48201, USA.

出版信息

J Pharmacol Exp Ther. 2007 Nov;323(2):586-98. doi: 10.1124/jpet.107.124610. Epub 2007 Aug 8.

Abstract

The effects of rifampicin treatment on SULT2A1 mRNA expression were evaluated in 23 preparations of primary cultured human hepatocytes. In contrast to the consistently occurring induction of CYP3A4, a prototypical pregnane X receptor (PXR) target gene, rifampicin treatment increased SULT2A1 mRNA levels in 12 of the hepatocyte preparations, but it produced little change or even suppression in the others. Transient transfection of HepG2 cells with a series of reporter constructs implicated two SULT2A1 5'-flanking regions as containing rifampicin-responsive information. Each of these regions contained a hepatocyte nuclear factor 4 (HNF4) binding site (at nucleotide [nt] -6160 and -54), as demonstrated by in vitro binding and site-directed mutagenesis. HNF4alpha bound to the HNF4-54 region of the endogenous SULT2A1 gene, as indicated by chromatin immunoprecipitation. Cotransfection of HepG2 cells with pregnane X receptor (PXR) dose-dependently suppressed reporter expression from SULT2A1 constructs containing the HNF4 sites, and rifampicin treatment augmented the suppression. Rifampicin treatment concentration-dependently suppressed SULT2A1 reporter expression at the same concentrations that progressively induced expression from a PXR-responsive CYP3A4 reporter, whereas higher rifampicin concentrations reversed the SULT2A1 suppression. The suppressive effect of rifampicin was diminished, whereas the activating effect was augmented, in HepG2 cells with RNA interference-mediated PXR knockdown. These results suggest that HNF4alpha plays a central role in the control of SULT2A1 transcription and that rifampicin-liganded PXR suppresses SULT2A1 expression by interfering with HNF4alpha activity. By contrast, the rifampicin-inducible SULT2A1 expression that occurs in many human hepatocyte preparations seems to be mediated through a PXR-independent mechanism.

摘要

在23份原代培养的人肝细胞制剂中评估了利福平治疗对SULT2A1 mRNA表达的影响。与细胞色素P450 3A4(一种典型的孕烷X受体(PXR)靶基因)持续出现的诱导情况相反,利福平治疗使12份肝细胞制剂中的SULT2A1 mRNA水平升高,但在其他制剂中变化不大甚至出现抑制。用一系列报告基因构建体瞬时转染HepG2细胞表明,两个SULT2A1 5'-侧翼区域含有利福平反应性信息。如体外结合和定点诱变所示,这些区域中的每一个都含有一个肝细胞核因子4(HNF4)结合位点(位于核苷酸[nt] -6160和-54处)。染色质免疫沉淀表明,HNF4α与内源性SULT2A1基因的HNF4-54区域结合。用孕烷X受体(PXR)共转染HepG2细胞可剂量依赖性地抑制含有HNF4位点的SULT2A1构建体的报告基因表达,而利福平治疗可增强这种抑制作用。利福平治疗在逐渐诱导PXR反应性CYP3A4报告基因表达的相同浓度下,浓度依赖性地抑制SULT2A1报告基因表达,而更高的利福平浓度可逆转SULT2A1的抑制作用。在RNA干扰介导的PXR敲低的HepG2细胞中,利福平的抑制作用减弱,而激活作用增强。这些结果表明,HNF4α在SULT2A1转录控制中起核心作用,并且利福平配体化的PXR通过干扰HNF4α活性来抑制SULT2A1表达。相比之下,许多人肝细胞制剂中出现的利福平诱导的SULT2A1表达似乎是通过一种不依赖PXR的机制介导的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验